9OM1.F - EXMceuticals Inc.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2020-06-30
2019-06-30
Cash flows from operating activities
Net Income
-9,627
-9,253
-9,689
Depreciation & amortization
152.513
139.101
-
Stock based compensation
4,491
1,019
-
Change in working capital
1,695
2,493
-240.951
Accounts receivable
-
-
-128.713
Accounts Payable
949.327
1,984
-
Other working capital
-970.38
-4,455
-5,996
Other non-cash items
1,656
1,285
4,888
Net cash provided by operating activites
-356.706
-3,357
-5,183
Cash flows from investing activities
Investments in property, plant and equipment
-613.674
-1,097
-812.976
Other investing activites
-
-
-671.76
Net cash used for investing activites
-613.674
-1,097
-1,482
Cash flows from financing activities
Debt repayment
-33.305
-19.031
-
Common stock issued
953
5
3,588
Other financing activites
-2,456
-9.267
2,599
Net cash used privided by (used for) financing activities
906.664
4,581
6,662
Net change in cash
56.596
124.887
-7.6
Cash at beginning of period
285.309
139.865
147.465
Cash at end of period
221.503
264.752
139.865
Free Cash Flow
Operating Cash Flow
-356.706
-3,357
-5,183
Capital Expenditure
-613.674
-1,097
-812.976
Free Cash Flow
-970.38
-4,455
-5,996